Is there an association between permethrin or doxycycline and exfoliative dermatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There is a potential association between doxycycline and exfoliative dermatitis, though it is relatively uncommon, and no clear association has been established with permethrin in the provided evidence. Doxycycline, an antibiotic commonly used for various infections including Lyme disease and acne, has been associated with severe cutaneous adverse reactions including exfoliative dermatitis, though this is considered rare 1. The mechanism behind these reactions typically involves hypersensitivity or immune-mediated responses to the medications. Patients with a history of drug allergies or dermatologic conditions may be at higher risk.

Key Considerations

  • Healthcare providers should monitor patients starting doxycycline, especially during the first few weeks of treatment when most severe cutaneous reactions tend to occur.
  • If a patient develops widespread redness, scaling, or peeling of the skin while using doxycycline, they should seek immediate medical attention.
  • Alternative medications should be considered for patients who have previously experienced severe skin reactions to doxycycline.

Management and Prevention

  • The use of doxycycline should be limited to the shortest possible duration, ideally 3-4 months, to minimize the risk of adverse events and antibiotic resistance 1.
  • Concomitant use of benzoyl peroxide and other topical therapy is recommended when using systemic antibiotics like doxycycline to reduce the development of antibiotic resistance and other complications 1.

From the FDA Drug Label

Exfoliative dermatitis has been reported but is uncommon. The association between doxycycline and exfoliative dermatitis is noted in the drug label, although it is described as uncommon.

  • There is no information about permethrin in the provided drug label. 2

From the Research

Association between Permethrin or Doxycycline and Exfoliative Dermatitis

  • There is no direct evidence in the provided studies to suggest an association between permethrin or doxycycline and exfoliative dermatitis 3, 4, 5, 6, 7.
  • The studies primarily focus on the treatment of scabies using permethrin and other medications, with no mention of exfoliative dermatitis as a side effect or associated condition.
  • Permethrin is shown to be an effective treatment for scabies, with some studies reporting mild skin reactions or irritant contact dermatitis as side effects 3, 4, 5, 6.
  • Doxycycline is not mentioned in any of the provided studies as a treatment for scabies or in relation to exfoliative dermatitis.
  • Further research would be needed to determine if there is any association between permethrin or doxycycline and exfoliative dermatitis, as the current evidence does not provide any insight into this topic 3, 4, 5, 6, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A new treatment regimen with permethrin in scabies.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018

Research

Interventions for treating scabies.

The Cochrane database of systematic reviews, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.